AMBEV S.A. current report, Q1 FY2020

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. reports consolidated transactions of securities and derivatives by management and related persons for the period of December 1, 2019, to December 31, 2019. The report was filed on January 8, 2020, in compliance with Article 11 of CVM Instruction # 358/2002.

Key Financial Metrics

The filing text does not provide corporate financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document exclusively details insider trading activity.

Group Transaction Type Securities Quantity Total Volume (R$)
Group and Related Persons Sell Common Shares 771,614 14,660,687.00
Group and Related Persons Sell ADR Common 530,000 10,106,184.69
Board of Directors Buy Common Shares (Deferred) 5,416 0.00
Board of Directors Sell Common Shares 733,800 14,103,636.00
Management None Common Shares 0 0.00

Material Changes

The filing does not provide comparative data against prior periods to determine material changes in trading volume or price. The document serves as a statutory disclosure of specific transactions occurring within the December 2019 window.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, financial guidance, outlook, risk factors, or contingencies. It is a compliance report regarding insider transactions only.

Investor Verification Checklist

  • Verify the total volume of Common Shares sold by the Group and Related Persons (771,614 shares) and the Board of Directors (733,800 shares).
  • Confirm the average sale price for Common Shares, which ranged between R$ 19.00 and R$ 19.22.
  • Note that the Board of Directors acquired 5,416 deferred shares at no cost (R$ 0.00).
  • Observe that the Management group reported no transactions during this period.
  • Check the final balance of Common Shares held by the Group (33,337,417) and the Board (7,056,863).